Delivery Order SPE2DB22D1202-SPE2DB23FHYD9
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,573 to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. As the prime contractor, Amerisourcebergen will fulfill the order for the ADHD medication to support the Defense Logistics Agency's logistics and procurement programs. No...
- The Defense Logistics Agency awarded a $1,774.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. Amerisourcebergen Drug Corporation will deliver the medication to a facility located in Conshohocken, Pennsylvania between August 10-11, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation which will perform under the contract. The Defense Logistics Agency is the funding agency for this...
- The Defense Logistics Agency awarded a $2,594.03 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from June 22 to June 23, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor in fulfilling this order to supply the attention deficit hyperactivity disorder medication to the DLA....
- The Defense Logistics Agency awarded a $4,420.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 10 mg Vyvanse. Amerisourcebergen Drug Corporation will deliver the capsules to a location in Conshohocken, Pennsylvania by August 4, 2023 under the terms of the order. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the Defense Logistics Agency's requirement for the specified medication in support of the agency's procurement...
- The Defense Logistics Agency awarded a $3,455.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order has a period of performance from August 8 to August 9, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the order for the stimulant medication to support the Defense Logistics Agency's medical supply needs. No...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,586 to Amerisourcebergen Drug Corporation for 100 capsules of 10 mg Vyvanse. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 14 through 15, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order for the attention deficit hyperactivity disorder...
- The Defense Logistics Agency awarded a $1,473.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 40mg Vyvanse. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 8-9, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. The Defense Logistics Agency is the contracting agency, likely procuring these...
- The Defense Logistics Agency awarded a $2,030.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 29 through August 30, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor in fulfilling this order for the stimulant medication Vyvanse to support the Defense...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,842 to Amerisourcebergen Drug Corporation for 100 capsules of Vyvanse 20 mg. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order begins on August 22, 2023 and is scheduled to conclude the following day. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor in fulfilling...
- The Defense Logistics Agency awarded a $3,401.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The one-day order runs from August 2 to August 3, 2023 to supply the attention deficit hyperactivity disorder medication to support DLA requirements. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products through its corporate...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHYD9Delivery Order
The Defense Logistics Agency awarded a $2,272.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 40mg Vyvanse. Amerisourcebergen Drug Corporation will deliver the capsules to a location in Conshohocken, Pennsylvania by August 11, 2023 under the terms of this order. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the Defense Logistics Agency's requirement for this commonly prescribed stimulant medication used to treat attention deficit hyperactivity disorder. No subcontractors or set aside designations were identified in the award information.
Generated 12/24/23, 1:54 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/10/23 |